US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Refresh Tears

Reason Labeling: Not elsewhere classified; product labeling lacks a NDC number, net weight information and does not contain the Drug Facts Panel.

Cell Distributors D-0865-2017
Class II · Moderate risk Terminated

Estradiol

Reason cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection

Medisca, Inc. NDC 38779-2261-04 D-0666-2017
Class II · Moderate risk Terminated

Estradiol

Reason cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection

Medisca, Inc. NDC 38779-0869-07 D-0665-2017
Class II · Moderate risk Terminated

Estrone

Reason cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection

Medisca, Inc. NDC 38779-0891-05 D-0664-2017
Class II · Moderate risk Terminated

Estriol

Reason cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection

Medisca, Inc. NDC 38779-0732-03 D-0663-2017
Class II · Moderate risk Terminated

Alka-Seltzer Gold

Reason Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.

Bayer HealthCare Pharmaceuticals, Inc. D-1051-2017
Class II · Moderate risk Terminated

Alka-Seltzer Extra Strength

Reason Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.

Bayer HealthCare Pharmaceuticals, Inc. D-1050-2017
Class II · Moderate risk Terminated

Alka-Seltzer Original

Reason Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.

Bayer HealthCare Pharmaceuticals, Inc. D-1044-2017
Class II · Moderate risk Terminated

hCG Body Shaper

Reason Marketed without an Approved NDA/ANDA; FDA analysis has found the product to be tainted with human chorionic gonadotropin, rendering it an unapproved drug

Gary Wood D-0677-2017
Class II · Moderate risk Terminated

Nystatin and Triamcinolone Acetonide Cream

Reason Failed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stability

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1263-1 D-0676-2017
Class II · Moderate risk Terminated

Levonorgestrel Non-Micronized

Reason cGMP Deviations; lack of quality assurance.

Qinhuangdao Zizhu Pharmaceutical, Co. NDC 44132-012-01 D-0660-2017
Class II · Moderate risk Terminated

Ethinyl Estradiol Micronized

Reason cGMP Deviations; lack of quality assurance.

Qinhuangdao Zizhu Pharmaceutical, Co. NDC 44132-002-05 D-0659-2017
Class II · Moderate risk Terminated

Testosterone Micronized

Reason cGMP Deviations; lack of quality assurance.

Qinhuangdao Zizhu Pharmaceutical, Co. NDC 44132-006-06 D-0658-2017
Class II · Moderate risk Terminated

Estrone Micronized

Reason cGMP Deviations; lack of quality assurance.

Qinhuangdao Zizhu Pharmaceutical, Co. NDC 44132-003-04 D-0657-2017
Class II · Moderate risk Terminated

Estriol Micronized

Reason cGMP Deviations; lack of quality assurance.

Qinhuangdao Zizhu Pharmaceutical, Co. D-0656-2017
Class II · Moderate risk Terminated

Estradiol Non-Micronized

Reason cGMP Deviations; lack of quality assurance.

Qinhuangdao Zizhu Pharmaceutical, Co. D-0655-2017
Class II · Moderate risk Terminated

Estradiol Micronized Bulk

Reason cGMP Deviations; lack of quality assurance.

Qinhuangdao Zizhu Pharmaceutical, Co. NDC 44132-001-01 D-0654-2017
Class II · Moderate risk Ongoing

Ventolin HFA

Reason Defective Delivery System: Elevated number of units with out of specification results for leak rate.

GlaxoSmithKline, LLC NDC 0173-0682-20 D-0626-2017
Class II · Moderate risk Terminated

Atorvastatin Calcium Tablets

Reason Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-208-20 D-0622-2017
Class II · Moderate risk Terminated

Atorvastatin Calcium Tablets

Reason Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Mylan Pharmaceuticals Inc. NDC 0378-3953-09 D-0621-2017
Class II · Moderate risk Terminated

Atorvastatin Calcium Tablets

Reason Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Mylan Pharmaceuticals Inc. NDC 0378-3952-09 D-0620-2017
Class II · Moderate risk Terminated

Atorvastatin Calcium Tablets

Reason Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Mylan Pharmaceuticals Inc. NDC 0378-3951-09 D-0619-2017
Class II · Moderate risk Terminated

Atorvastatin Calcium Tablets

Reason Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Mylan Pharmaceuticals Inc. NDC 0378-3950-77 D-0618-2017
Class II · Moderate risk Terminated

Latanoprost Ophthalmic Solution

Reason Lack of assurance of sterility: product was found to be empty, under-filled, or leaking.

Akorn, Inc. NDC 17478-625-12 D-0661-2017
Class II · Moderate risk Terminated

Kalbitor

Reason Presence of Particulate Matter: Glass

Shire NDC 47783-101-01 D-0625-2017